Global Circulating Tumor Cell (CTC) Diagnostics Market to Reach $21.3 Billion by 2030
The global market for Circulating Tumor Cell (CTC) Diagnostics estimated at US$9.1 Billion in the year 2022, is projected to reach a revised size of US$21.3 Billion by 2030, growing at a CAGR of 11.2% over the analysis period 2022-2030. Detection & Enrichment, one of the segments analyzed in the report, is projected to record a 10.8% CAGR and reach US$13.8 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Analysis segment is readjusted to a revised 12.8% CAGR for the next 8-year period.The U.S. Market is Estimated at $2.7 Billion, While China is Forecast to Grow at 10.3% CAGR
The Circulating Tumor Cell (CTC) Diagnostics market in the U.S. is estimated at US$2.7 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$3.6 Billion by the year 2030 trailing a CAGR of 10.3% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 10.2% and 9.5% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 7.9% CAGR.Select Competitors (Total 48 Featured) -
- ApoCell, Inc.
- Biocep Ltd.
- Biocept, Inc.
- Biofluidica Microtechnologies LLC
- Celltraffix Inc.
- Clearbridge Biomedics
- Creatv Microtech, Inc.
- Cynvenio Biosystems, Inc.
- Fluxion Biosciences, Inc.
- Ikonisys, Inc.
- IVDiagnostics, Inc.
- Janssen Diagnostics LLC
- QIAGEN Hannover GmbH
- Rarecells Sas
- Screencell
- Stemcell Technologies, Inc.
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- ApoCell, Inc.
- Biocep Ltd.
- Biocept, Inc.
- Biofluidica Microtechnologies LLC
- Celltraffix Inc.
- Clearbridge Biomedics
- Creatv Microtech, Inc.
- Cynvenio Biosystems, Inc.
- Fluxion Biosciences, Inc.
- Ikonisys, Inc.
- IVDiagnostics, Inc.
- Janssen Diagnostics LLC
- QIAGEN Hannover GmbH
- Rarecells Sas
- Screencell
- Stemcell Technologies, Inc.
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 196 |
Published | March 2024 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 9.1 Billion |
Forecasted Market Value ( USD | $ 21.3 Billion |
Compound Annual Growth Rate | 11.2% |
Regions Covered | Global |